Publications 2010

Ameille J, Letourneux M, Paris C, Brochard P, Stoufflet A, Schorle E, Gislard A, Laurent F, Conso F, Pairon JC. Does asbestos exposure cause airway obstruction, in the absence of confirmed asbestosis? Am J Respir Crit Care Med. 2010 Aug 15;182(4):526-30. IF:10,19

———————————————————————————————————————————————————

Andujar P, Wang J, Descatha A, Galateau-Sallé F, Abd-Alsamad I, Billon-Galland MA, Blons H, Clin B, Danel C, Housset B, Laurent-Puig P, Le Pimpec-Barthes F, Letourneux M, Monnet I, Régnard JF, Renier A, Zucman-Rossi J, Pairon JC, Jaurand MC. p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. Lung Cancer. 2010 Jan;67(1):23-30. IF:3,556

———————————————————————————————————————————————————

Aouba A, Georgin-Lavialle S, Pagnoux C, Martin Silva N, Renand A, Galateau-Salle F, Le Toquin S, Bensadoun H, Larousserie F, Silvera S, Provost N, Candon S, Seror R, de Menthon M, Hermine O, Guillevin L, Bienvenu B. Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood. 2010 Nov 18;116(20):4070-6.

———————————————————————————————————————————————————

Babin E, Grandazzi G. Vivre avec le cancer : La vie des conjoints de patients laryngectomisés ; Psycho-onco 2010, vol4,n°4,p303-8 IF:2,874.

———————————————————————————————————————————————————

Bergot E, Magnier R, Zalcman G. Phosphodiesterase inhibitors for pulmonary hypertension. N Engl J Med. 2010 Feb 11;362(6):559; author reply 560.

———————————————————————————————————————————————————

Berchi C, Guittet L, Bouvier V, Launoy G. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening. International Journal of Technology Assessment in Health Care 2010 ; 26(1) : 48-53. IF:1,365

———————————————————————————————————————————————————

Bergot E, Magnier R, Zalcman G. Phosphodiesterase inhibitors for pulmonary hypertension. N Engl J Med. 2010 Feb 11;362(6):559; author reply 560. IF:53,484

———————————————————————————————————————————————————

Billet S, Paget V, Garçon G, Heutte N, André V, Shirali P, Sichel F. Benzene-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the functional analysis of separated alleles in yeast, in human lung cells. Arch Toxicol. 2010 Feb;84(2):99-107. IF:4,041

———————————————————————————————————————————————————

Blanchard D, Hibon R, Hitier M, Galateau-Sallé F, Abadie-Koebele C, Babin E. [Cranial fasciitis of childhood]. Rev Laryngol Otol Rhinol (Bord).
2010;131(4-5):289-93.

———————————————————————————————————————————————————

Bouvier AM, Sant M, Verdecchia A, Forman D, Damhuis R, Willem Coebergh J, Crocetti E, Crosignani P, Gafa L, Launoy G, Martinez-Garcia C, Plesko I, Pompe-Kirn V, Rachtan J, Velten M, Vercelli M, Zwierko M, Esteve J, FAIVRE J. What reasons lie behind differences in long-term survival for gastric cancer within Europe. Eur J Cancer 2010;46(6):1086-1092. IF:4,944

———————————————————————————————————————————————————

Bridoux V, Moutel G, Lefebure B, Scotte M, Michot F, Herve C, Tuech JJ. Reporting on quality of life in randomised controlled trials in gastrointestinal surgery. J Gastrointest Surg. 2010 Jan;14(1):156-65.

———————————————————————————————————————————————————

Castrale C, Evans D, Verger C, Fabre E, Aguilera D, Ryckelynck JP, Lobbedez T. Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF). Nephrol Dial Transplant. 2010 Jan;25(1):255-62.

———————————————————————————————————————————————————

Chantepie SP, Vaur D, Grunau C, Salaün V, Briand M, Parienti JJ, Heutte N, Cheze S, Roussel M, Gauduchon P, Leporrier M, Krieger S. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia. Leuk Res. 2010 Jun;34(6):800-8. IF:2,555

———————————————————————————————————————————————————

Châtelet V, Lobbedez T, Frémeaux-Bacchi V, Ficheux M, Ryckelynck JP, Hurault de Ligny B. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report. Transplant Proc. 2010 Dec;42(10):4353-5.

———————————————————————————————————————————————————

Choussy O, Ferron C, Védrine PO, Toussaint B, Liétin B, Marandas P, Babin E, De Raucourt D, Reyt E, Cosmidis A, Makeieff M, Dehesdin D. Role of radiotherapy in the treatment of nasoethmoidal adenocarcinoma. Arch Otolaryngol Head Neck Surg. 2010 Feb;136(2):143-6. IF:1,571

———————————————————————————————————————————————————

Ciappuccini R, Ansemant T, Maillefert JF, Tavernier C, Ornetti P. Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol. 2010 Nov-Dec;28(6 Suppl 63):S131-3.

———————————————————————————————————————————————————

Clin B, Ophélie F. Law of 22 April 2005 on patients’ rights and the end of life in France: setting the boundaries of euthanasia, with regard to current
legislation in other European countries. Med Sci Law. 2010 Oct;50(4):183-8. IF:0,290

———————————————————————————————————————————————————

Colonna M, Bossard N, Guizard AV, Remontet L, Grosclaude P; le réseau FRANCIM. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol (Paris). 2010 Mar;71(2):95-101. IF:0,583

———————————————————————————————————————————————————

Covic A, Bammens B, Lobbedez T, Segall L, Heimbürger O, van Biesen W, Fouque D, Vanholder R. Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board. Nephrol Dial Transplant. 2010 Jun;25(6):1757-9

———————————————————————————————————————————————————

Dayan J, Creveuil C, Dreyfus M, Herlicoviez M, Baleyte JM, O’Keane V. Developmental model of depression applied to prenatal depression: role of present and past life events, past emotional disorders and pregnancy stress. PLoS One. 2010 Sep 22;5(9):e12942. IF:4,411

———————————————————————————————————————————————————

Delas B, Bertrand M, Babin E, François A, Marie JP, Dehesdin D, Choussy O. Nasolacrimal duct oncocytoma: an unusual cause of chronic epiphora. Ear Nose Throat J. 2010 Mar;89(3):132-9. IF:0,595

———————————————————————————————————————————————————

Du Bois A, Herrstedt J, Hardy-Bessard AC, Müller HH, Harter P, Kristensen G, Joly F, Huober J, Avall-Lundqvist E, Weber B, Kurzeder C, Jelic S, Pujade-Lauraine E, Burges A, Pfisterer J, Gropp M, Staehle A, Wimberger P, Jackisch C, Sehouli J. Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer. J Clin Oncol. 2010 Sep 20;28(27):4162-9. IF:18,970

———————————————————————————————————————————————————

Fritschi L, Guenel P, Ahrens W; European Study Group on Occupational Causes of Rare Cancers. Breast cancer in priests: follow-up of an observation made 167 years ago. Eur J Epidemiol. 2010 Mar;25(3):219-21. IF:4,535

———————————————————————————————————————————————————

Eymard JC, Oudard S, Gravis G, Ferrero JM, Theodore C, Joly F, Priou F, Krakowski I, Zannetti A, Thill L, Beuzeboc P. Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study. BJU Int. 2010 Oct;106(7):974-8. IF:3,190

———————————————————————————————————————————————————

Franrenet S, Duchange N, Galactéros F, Quantin C, Cohen O, Nzouakou R, Sudraud S, Hervé C, Moutel G. Ethical issues related to computerised family medical histories in sickle cell disease: Inforare. J Med Ethics. 2010 Oct;36(10):604-7.

———————————————————————————————————————————————————

Gatta G, Capocaccia R, Trama A, Martínez-García C; RARECARE Working Group. The burden of rare cancers in Europe. Adv Exp Med Biol. 2010;686:285-303. IF:1,379

———————————————————————————————————————————————————

Giorgi R, Belot A, Gaudart J, Launoy G, and the French Network of Cancer Registries Francim.Authors’ Reply to the Letter to the Editor: Horton NJ, White IR, Carpenter J. The performance of multiple imputation for missing covariates relative to complete case analysis. Stat Med 2010;29(12):1357; author reply 1358. IF:2,328

———————————————————————————————————————————————————

Guittet L, Launoy G. Screening for colorectal cancer. N Engl J Med. 2010;362:84-5. IF:53,484

———————————————————————————————————————————————————

Gunzer K, Clarisse B, Lheureux S, Delcambre C, Joly F. Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data. Expert Opin Biol Ther. 2010 Apr;10(4):615-30. IF:3,279

———————————————————————————————————————————————————

Hamon M, Fau G, Née G, Ehtisham J, Morello R, Hamon M. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson. 2010 May 19;12:29. IF:4,328

———————————————————————————————————————————————————

Jambon C, Dejardin O, Morlais F, Pornet C, Bouvier V, Launoy G. Social and geographical determinants of care management in France – colorectal cancer incidence in Calvados from 1997 to 2004. Rev Epidemiol Sante Publique 2010;58(3):207-1. PMID:20417044. IF:1,247

———————————————————————————————————————————————————

Jegu J, Tretarre B, Velten M, Guizard AV, Danzon A, Buemi A, Colonna M, Kadi-Hanifi AM, Ganry O, Molinie F, Bara S, Rebillard X, Grosclaude P. [Prostate cancer management and factors associated with radical prostatectomy in France in 2001]. Prog Urol. 2010 Jan;20(1):56-64. IF:0,481

———————————————————————————————————————————————————

Joly F, Degrendel AC, Guizard AV. [Quality of life after radiotherapy for prostate cancer]. Cancer Radiother. 2010 Oct;14(6-7):519-25. IF:1,306

———————————————————————————————————————————————————

Joly F, Sevin E, Lortholary A, Priou F, Paitel JF, Fabbro M, Henry-Amar M, Hamond K, Bourgeois H. Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial. Gynecol Oncol 2010;116(3):312-316. IF:3,760

———————————————————————————————————————————————————

Labiche A, Heutte N, Herlin P, Chasle J, Gauduchon P, Elie N. Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma. Int J Gynecol 2 Cancer. 2010; 20 :28-33. IF:1,558

———————————————————————————————————————————————————

Lacourt A, Rolland P, Gramond C, Astoul P, Chamming’s S, Ducamp S, Frenay C, Galateau-Sallé F, Gilg Soit Ilg A, Imbernon E, Le Stang N, Pairon JC, Goldberg M, Iwatsubo Y, Salmi LR, Brochard P. Attributable risk in men in two French case-control studies on mesothelioma and asbestos. Eur J Epidemiol. 2010 ; 25:799-806. IF:4,535

———————————————————————————————————————————————————

Lagadu S, Lechevrel M, Sichel F, Breton J, Pottier D, Couderc R, Moussa F, Prevost V. 8-oxo-7,8-dihydro-2’-deoxyguanosine as a biomarker of oxidative damage in oesophageal cancer patients: lack of association with antioxidant vitamins and polymorphism of hOGG1 and GST, Journal of Experimental and Clinical Cancer Research, 2010; 29:157. IF:1,921

———————————————————————————————————————————————————

Lagadu S, Pottier I, Sichel F, Laurent C, Lefaix J-L, Prevost V. Detection of extracellular 8-oxo-7,8-dihydro-2’-deoxyguanosine as a biomarker of oxidative damage in X-irradiated fibroblast cultures: optimization of analytical procedure, Biomarkers 2010; 15: 707-714. IF:2,090

———————————————————————————————————————————————————

Lagrange JL, Bascoul-Mollevi C, Geoffrois L, Beckendorf V, Ferrero JM, Joly F, Allouache N, Bachaud JM, Chevreau C, Kramar A, Chauvet B; Study Group on Genito-Urinary Tumors. Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015). Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):172-8. IF:4,503

———————————————————————————————————————————————————

Lanier C, Richard E, Heutte N, Picquet R, Bouchart V, Garon D. Airborne Molds And Mycotoxins Associated With Handling Of Corn Silage And Oilseed Cakes In Agricultural Environment. Atmospheric Environment 2010; 44 :1980-6. IF:3,226

———————————————————————————————————————————————————

Launoy G; FRANCIM. [Epidemiology of cancers in France]. Rev Prat. 2010 Feb 20;60(2):178-82.

———————————————————————————————————————————————————

Le Stang N, Belot A, Gilg Soit Ilg A, Rolland P, Astoul P, Bara S, Brochard P, Danzon A, Delafosse P, Grosclaude P, Guizard AV, Imbernon E, Lapôtre-Ledoux B, Ligier K, Molinié F, Pairon JC, Sauleau EA, Trétarre B, Velten M, Bossard N, Goldberg M, Launoy G, Galateau-Sallé F. Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005. Int J Cancer. 2010 Jan 1;126(1):232-8. IF:4,926

———————————————————————————————————————————————————

Lepage C, Ciccolallo L, De Angelis R, Bouvier AM, Faivre J, Gatta G; EUROCARE working group. European disparities in malignant digestive endocrine tumours survival. Int J Cancer. 2010 Jun 15;126(12):2928-34. IF:4,926

———————————————————————————————————————————————————

Luna BA, Chraibi M, Abd IA, Coste A, Babin E. [Sinonasal hemangiopericytoma: review of four cases]. Rev Laryngol Otol Rhinol (Bord). 2010;131(3):207-12.

———————————————————————————————————————————————————

Méjean A, Guy L, Jacqmin D, Joly F, Négrier S, Pignot G.[Metastatic renal cell carcinoma: pretherapeutic approach before antiangiogenic treatment. A case report]. [Article in French] Prog Urol. 2010 Mar;20 Suppl 1:S16-9.  Prog Urol. 2010 Mar;20 Suppl 1:S16-9. IF:0,481

———————————————————————————————————————————————————

Morel N, Eustache F, Lange M, Joly F, Giffard B. L’impact du cancer et de ses traitements sur les fonctions cognitives : l’exemple du cancer du sein. Revue de neuropsychologie 2010 ; 2(3), 250 – 254. IF:0,528

———————————————————————————————————————————————————

Morère J, Bréchot JM, Westeel V, Gounant V, Lebeau B, Vaylet F, Barlési F, Urban T, Souquet PJ, Debieuvre D, Baudrin L, Zalcman G, Morin F, Milleron B, Moro-Sibilot D. Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study). Lung Cancer. 2010 Dec;70(3):301-7. IF:3,356

———————————————————————————————————————————————————

Moutel G, Goussot-Souchet M, Plu I, Pierre M, Leclercq T, Coffin JC, Duchange N. [Fetuses born lifeless: new representations and new rights]. [Article in French] Med Sci (Paris). 2010 Aug-Sep;26(8-9):772-7.

———————————————————————————————————————————————————

Nayaradou M, Berchi C, Dejardin O, Launoy O. Eliciting population preferences for mass colorectal cancer screening organization. Medical Decision Making 2010; 30 : 224-233. IF:2,013

———————————————————————————————————————————————————

Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Ségura C, Collet F, Allouache D, Switsers O, Delcambre C, Delozier T, Henry-Amar M, Joly F. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011 Nov1;81(3):795-803

———————————————————————————————————————————————————

Ollivier I, Dauvois B, Guittet L, Boutreux S, Dupont B, Launoy G, Dao T. Survival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002. Gastroenterol Clin Biol. 2010;34:288-96. IF:0,726

———————————————————————————————————————————————————

Orgerie MB, Duchange N, Pélicier N, Chapet S, Dorval E, Rosset P, Lemarié E, Hervé C, Moutel G. [Decision process in oncology: the importance of multidisciplinary meeting]. [Article in French] Bull Cancer. 2010 Feb;97(2):255-64.

———————————————————————————————————————————————————

Paris C, Maurel M, Luc A, Stoufflet A, Pairon JC, Letourneux M. CT scan screening is associated with increased distress among subjects of the APExS. BMC Public Health. 2010 Oct 26;10:647.

———————————————————————————————————————————————————

Pautier P, Joly F, Kerbrat P, Bougnoux P, Fumoleau P, Petit T, Rixe O, Ringeisen F, Carrasco AT, Lhommé C. Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074). Gynecol Oncol. 2010 Feb;116(2):157-62. IF:3, 76

———————————————————————————————————————————————————

Phelip JM, Molinié F, Delafosse P, Launoy G, Trétarre B, Bara S, Buémi A, Velten M, Danzon A, Ganry O, Bouvier AM, Grosclaude P, Faivre J. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancer. Gatroenterol Clin Biol. 2010 34;2:144-149.  IF:0,726

———————————————————————————————————————————————————

Pluquet E, Cadranel J, Legendre A, Faller MB, Souquet PJ, Zalcman G, Perol M, Fraboulet G, Oliveiro G, De Fraipont F, Quoix E, Lantuejoul S, Milleron B, Moro-Sibilot D. Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survival. J Thorac Oncol. 2010 Apr;5(4):491-6. IF:4,04

———————————————————————————————————————————————————

Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic and health care supply statistical determinants of compliance to mammography screening programs: A multilevel analysis in Calvados, France. Cancer Epidemiology 2010; 34(3):309-15 PMID: 20403737

———————————————————————————————————————————————————

Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Comm Health 2010;64:318-4. PMID: 19740776

———————————————————————————————————————————————————

Pujade-Lauraine E, Wagner U, Aavall-Lundqvist E, Gebski V, Heywood M, Vasey PA, Volgger B, Vergote I, Pignata S, Ferrero A, Sehouli J, Lortholary A, Kristensen G, Jackisch C, Joly F, Brown C, Le Fur N, du Bois A. Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse. J Clin Oncol. 2010 Jul 10;28(20):3323-9.

———————————————————————————————————————————————————

Roggli VL, Gibbs AR, Attanoos R, Churg A, Popper H, Cagle P, Corrin B, Franks TJ, Galateau-Salle F, Galvin J, Hasleton PS, Henderson DW, Honma K. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010 Mar;134(3):462-80.

———————————————————————————————————————————————————

Rolland P, Gramond C, Briand A, Astoul P, Chamming’s S, Ducamp S, Frenay C, Galateau-Sallé F, Gilg Soit Ilg A, Imbernon E, Le Stang N, Pairon JC, Goldberg G, Brochard P. Occupations and industries in France at high risk for pleural mesothelioma: a population-based case-control study (1998-2002). Am J Ind Med 2010, 2010 ; 53:1207-19.

———————————————————————————————————————————————————

Rousseau F, Retornaz F, Joly F, Esterni B, Abadie-Lacourtoisie S, Fargeot P, Luporsi E, Servent V, Laguerre B, Brain E, Geneve J. Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO). Crit Rev Oncol Hematol 2010;76(1):71-8

———————————————————————————————————————————————————

Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, Le Péchoux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010 Mar;35(3):479-95.

———————————————————————————————————————————————————

Terzi N, Pelieu I, Guittet L, Ramakers M, Seguin A, Daubin C, Charbonneau P, du Cheyron D, Lofaso F. Neurally adjusted ventilatory assist in patients recovering spontaneous breathing after acute respiratory distress syndrome : physiological evaluation. Crit Care Med. 2010 Sep;38(9):1830-7.

———————————————————————————————————————————————————

Tortosa JC, Rodríguez-Arias Vailhen D, Moutel G. [Ethical issues raised by 2 kinds of protocols for organ donation after cardiac death: aspects particular to France, Spain and the United States]. [Article in French] Med Sci (Paris). 2010 Feb;26(2):209-13.

———————————————————————————————————————————————————

Turner PC, Hopton RP, Lecluse Y, White KL, Fisher J, Lebailly P. Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. J Agric Food Chem. 2010 ;58:5206-12.

———————————————————————————————————————————————————

Verneuil L, Gouarin S, Comoz F, Agbalika F, Creveuil C, Varna M, Vabret A, Janin A, Leroy D. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up. Br J Dermatol. 2010 Jul;163(1):174-82.

———————————————————————————————————————————————————

Zagdoun E, Ficheux M, Lobbedez T, Chatelet V, Thuillier-Lecouf A, Bensadoun H, Ryckelynck JP, Hurault de Ligny B. Complicated lymphoceles after kidney transplantation. Transplant Proc. 2010 Dec;42(10):4322-5.

———————————————————————————————————————————————————

Zalcman G, Bergot E, Lechapt E. Update on nonsmall cell lung cancer. Eur Respir Rev. 2010 Sep;19(117):173-85.